Pomerantz LLP Informs Investors of Class Action Against Telix Pharmaceuticals Limited – TLX
NEW YORK CITY, NY / ACCESS Newswire / November 30, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Telix Pharmaceuticals Limited ("Telix" or the "Company") (NASDAQ:TLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are […]